These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33993680)
1. [Susceptibility of animal species to experimental SARS-CoV-2 ( Petrova NV; Ganina KK; Tarasov SA Vopr Virusol; 2021 May; 66(2):103-111. PubMed ID: 33993680 [TBL] [Abstract][Full Text] [Related]
2. [Specific features of the pathology of the respiratory system in SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus: Sarbecovirus) infected Syrian hamsters (Mesocricetus auratus)]. Chepur SV; Alekseeva II; Vladimirova OO; Myasnikov VA; Tyunin MA; Ilinskii NS; Nikishin AS; Shevchenko VA; Smirnova AV Vopr Virusol; 2022 Jan; 66(6):442-451. PubMed ID: 35019251 [TBL] [Abstract][Full Text] [Related]
3. [An electron microscopic study of neocortex of Syrian hamsters ( Paramonova NM; Chepur SV; Pervak MО; Myasnikov VA; Tyunin MA; Ilinskiy NS; Kanevskij BA; Smirnova AV Vopr Virusol; 2022 Nov; 67(5):403-413. PubMed ID: 36515286 [TBL] [Abstract][Full Text] [Related]
4. [Clinical symptoms and signs in hamsters during experimental infection with the SARS-CoV-2 virus (Coronaviridae: Tuyskanova MS; Zhugunissov KD; Ozaslan M; Myrzakhmetova BS; Kutumbetov LB Vopr Virusol; 2023 Dec; 68(6):513-525. PubMed ID: 38156567 [TBL] [Abstract][Full Text] [Related]
5. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Rosenke K; Meade-White K; Letko M; Clancy C; Hansen F; Liu Y; Okumura A; Tang-Huau TL; Li R; Saturday G; Feldmann F; Scott D; Wang Z; Munster V; Jarvis MA; Feldmann H Emerg Microbes Infect; 2020 Dec; 9(1):2673-2684. PubMed ID: 33251966 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Sia SF; Yan LM; Chin AWH; Fung K; Choy KT; Wong AYL; Kaewpreedee P; Perera RAPM; Poon LLM; Nicholls JM; Peiris M; Yen HL Nature; 2020 Jul; 583(7818):834-838. PubMed ID: 32408338 [TBL] [Abstract][Full Text] [Related]
7. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A mBio; 2021 Apr; 12(2):. PubMed ID: 33879586 [TBL] [Abstract][Full Text] [Related]
8. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility. Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622 [TBL] [Abstract][Full Text] [Related]
9. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]. Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715 [TBL] [Abstract][Full Text] [Related]
10. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]. Lvov DK; Alkhovsky SV Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection of Chinese hamsters (Cricetulus griseus) reproduces COVID-19 pneumonia in a well-established small animal model. Bertzbach LD; Vladimirova D; Dietert K; Abdelgawad A; Gruber AD; Osterrieder N; Trimpert J Transbound Emerg Dis; 2021 May; 68(3):1075-1079. PubMed ID: 32946664 [TBL] [Abstract][Full Text] [Related]
12. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome. Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L mBio; 2020 Sep; 11(5):. PubMed ID: 32978313 [TBL] [Abstract][Full Text] [Related]
13. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Yang J; Wang W; Chen Z; Lu S; Yang F; Bi Z; Bao L; Mo F; Li X; Huang Y; Hong W; Yang Y; Zhao Y; Ye F; Lin S; Deng W; Chen H; Lei H; Zhang Z; Luo M; Gao H; Zheng Y; Gong Y; Jiang X; Xu Y; Lv Q; Li D; Wang M; Li F; Wang S; Wang G; Yu P; Qu Y; Yang L; Deng H; Tong A; Li J; Wang Z; Yang J; Shen G; Zhao Z; Li Y; Luo J; Liu H; Yu W; Yang M; Xu J; Wang J; Li H; Wang H; Kuang D; Lin P; Hu Z; Guo W; Cheng W; He Y; Song X; Chen C; Xue Z; Yao S; Chen L; Ma X; Chen S; Gou M; Huang W; Wang Y; Fan C; Tian Z; Shi M; Wang FS; Dai L; Wu M; Li G; Wang G; Peng Y; Qian Z; Huang C; Lau JY; Yang Z; Wei Y; Cen X; Peng X; Qin C; Zhang K; Lu G; Wei X Nature; 2020 Oct; 586(7830):572-577. PubMed ID: 32726802 [TBL] [Abstract][Full Text] [Related]
14. J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases. Lee H; Lee TY; Jeon P; Kim N; Kim JW; Yang JS; Kim KC; Lee JY J Virol Methods; 2022 Jan; 299():114306. PubMed ID: 34601000 [TBL] [Abstract][Full Text] [Related]
15. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2). Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241 [TBL] [Abstract][Full Text] [Related]
16. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis. Sun SH; Chen Q; Gu HJ; Yang G; Wang YX; Huang XY; Liu SS; Zhang NN; Li XF; Xiong R; Guo Y; Deng YQ; Huang WJ; Liu Q; Liu QM; Shen YL; Zhou Y; Yang X; Zhao TY; Fan CF; Zhou YS; Qin CF; Wang YC Cell Host Microbe; 2020 Jul; 28(1):124-133.e4. PubMed ID: 32485164 [TBL] [Abstract][Full Text] [Related]
17. Hamster models of COVID-19 pneumonia reviewed: How human can they be? Gruber AD; Firsching TC; Trimpert J; Dietert K Vet Pathol; 2022 Jul; 59(4):528-545. PubMed ID: 34856819 [TBL] [Abstract][Full Text] [Related]
18. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409 [TBL] [Abstract][Full Text] [Related]
19. Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Zhang C; Zhou C; Shi L; Liu G Hum Vaccin Immunother; 2020 Oct; 16(10):2366-2369. PubMed ID: 32961082 [TBL] [Abstract][Full Text] [Related]
20. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]